Her proposed case-control study (participants that achieved abstinence for at least 6 months after smoking cessation versus participants that did not achieve abstinence) aims to identify novel genetically-supported drug targets for smoking cessation and to correlate/associate changes in those druggable protein targets with: (a) motivation to quit smoking and (b) vulnerability to relapse following abstinence.

For more information, please visit: https://www.ucy.ac.cy/onisilos/wp-content/uploads/sites/169/2023/12/A.G-ONISILOS-MSCA-COFUND-FELLOW.pdf